Search

everythinglearnresearchcommunity

for

Search:↓

Certain hydroxycinnamate derivatives may effectively inhibit enzymes linked to hair loss with low toxicity.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Ozenoxacin reduces sebum production, helping manage acne.

Sorafenib can cause a unique skin reaction.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

The fish oil-based gel with imiquimod improves skin cancer treatment and reduces inflammation.

Special nanoparticles increased skin absorption of hair loss treatments with fewer side effects.

Finasteride may help prevent prostate cancer.

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

Compound 4 is a promising treatment for hair loss with low toxicity.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

SARMs show promise but need more evidence to prove they're better than traditional androgens.

Two new compounds were found to build bone and muscle without affecting reproductive organs and skin oil glands.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

The compound improved hair growth and reduced hair loss.

A new treatment effectively kills antibiotic-resistant bacteria and helps wounds heal faster by boosting the immune response.

Blocking mTORC1 reduces skin tumor growth in mice.

The microreactor effectively fights antibiotic-resistant infections and promotes tissue healing.

Immune checkpoint inhibitors can cause scalp inflammation and hair follicle issues.

New treatments may restore cancer-blocking proteins, slow prostate cancer, identify drug targets, and potentially regrow hair.

Modifying steroidal inhibitors shows promise for developing new cancer treatments.

New patents show progress in developing drugs targeting the Wnt pathway for diseases like cancer and hair loss.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

NSC167409 can effectively inhibit the virus causing hand, foot, and mouth disease.

Melanogenesis inhibitors like kojic acid and niacinamide can reduce inflammation and pigment production in skin cells.

Certain inhibitors applied to the skin can promote hair growth by maintaining a key hair growth signal.

Stopping mitochondrial respiration can prevent brain cancer spread in skin cancer patients, and plant compound β-sitosterol could help achieve this.

Blocking CYP17A1 enzyme may help improve certain brain function issues related to dopamine.

Setipiprant may reduce inflammation by blocking an enzyme called aldose reductase.